» Articles » PMID: 38339172

Fuch's Endothelial Corneal Dystrophy in Cataract Patients Is Associated with Elevated Levels of Inflammatory Chemokines, but Not Growth Factors, in the Aqueous Humor

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Feb 10
PMID 38339172
Authors
Affiliations
Soon will be listed here.
Abstract

The study investigated a profile of chemokines and growth factors in the aqueous humor (AH) of eyes with Fuch's endothelial corneal dystrophy (FECD) and cataracts in comparison with cataract patients as a control group. A total of 52 AH samples (26 FECD + cataract and 26 cataract/control) were collected before cataract surgery. None of the patients had any clinically apparent inflammation at the time of AH collection. The AH levels of MCP-1 (CCL2), MIP-1α (CCL3), MIP-1β(CCL4), RANTES (CCL5), eotaxin (CCL11), IP-10 (CXCL10), FGF basic, G-CSF, GM-CSF, PDGF-bb, and VEGF were compared between the groups. The analyses were performed using the Bio-Plex 200 System from Bio-Rad. Among the studied parameters, the AH levels of RANTES, eotaxin, and IP-10 significantly increased in the FECD + cataract eyes, compared with the cataract controls ( < 0.05). Elevated levels of the RANTES, Eotaxin, and IP-10 indicate more intense inflammation in the eyes of patients in the FECD + cataract group. Moreover, these factors exhibit potential as predictive biomarkers for early detection of FECD in cataract patients. The discovery of elevated concentrations of biochemical markers in a patient, who has not yet received a clinical diagnosis, may suggest the need for heightened observation of the other eye to monitor the potential development of FECD.

Citing Articles

Association of triglyceride-glucose index and derived indices with cataract in middle-aged and elderly Americans: NHANES 2005-2008.

Wei B, Hu X, Shu B, Huang Q, Chai H, Yuan H Lipids Health Dis. 2025; 24(1):48.

PMID: 39953544 PMC: 11827319. DOI: 10.1186/s12944-025-02470-4.


Molecular Changes in Aqueous Humor Associated with Inflammation Following Cataract Surgery in Patients with Fuchs' Endothelial Corneal Dystrophy.

Chychko L, Son H, Friedrich M, Khoramnia R, Auffarth G, Augustin V Ophthalmol Ther. 2024; 14(1):197-209.

PMID: 39581953 PMC: 11724821. DOI: 10.1007/s40123-024-01072-0.


Expression of Hormones' Receptors in Human Corneal Endothelium from Fuchs' Dystrophy: A Possible Gender' Association.

De Piano M, Abicca I, Dinu V, Roszkowska A, Micera A, Schiano-Lomoriello D J Clin Med. 2024; 13(13).

PMID: 38999352 PMC: 11242089. DOI: 10.3390/jcm13133787.


Selective Upregulation of Interleukin 1 Receptor Antagonist and Interleukin-8 in Fuchs' Endothelial Corneal Dystrophy with Accompanying Cataract.

Fiolka R, Wylegala E, Toborek M, Adamczyk-Zostawa J, Czuba Z, Wylegala A J Clin Med. 2024; 13(10).

PMID: 38792359 PMC: 11121793. DOI: 10.3390/jcm13102815.

References
1.
Angiolillo A, Sgadari C, Taub D, Liao F, Farber J, Maheshwari S . Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med. 1995; 182(1):155-62. PMC: 2192108. DOI: 10.1084/jem.182.1.155. View

2.
Thaung C, Davidson A . Fuchs endothelial corneal dystrophy: current perspectives on diagnostic pathology and genetics-Bowman Club Lecture. BMJ Open Ophthalmol. 2022; 7(1). PMC: 9341215. DOI: 10.1136/bmjophth-2022-001103. View

3.
Grayson M, Holtzman M . Chemokine signaling regulates apoptosis as well as immune cell traffic in host defense. Cell Cycle. 2006; 5(4):380-3. DOI: 10.4161/cc.5.4.2427. View

4.
Miyagawa Y, Murakami A, Ebihara N . The proteolytic effect of mast cell tryptase to eotaxin-1/CCL11·eotaxin-2/CCL24 and eotaxin-3/CCL26 produced by conjunctival fibroblasts. Jpn J Ophthalmol. 2019; 63(2):215-220. DOI: 10.1007/s10384-019-00655-w. View

5.
Singh S, Anshita D, Ravichandiran V . MCP-1: Function, regulation, and involvement in disease. Int Immunopharmacol. 2021; 101(Pt B):107598. PMC: 8135227. DOI: 10.1016/j.intimp.2021.107598. View